Results 1 to 10 of about 99,201 (311)

Special Issue: Antibody Therapy for Hematologic Malignancies. [PDF]

Int J Mol Sci
It was recently reported that hematologic malignancies represented 6 [...
Butchar JP.
europepmc   +2 more sources

Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors. [PDF]

Front Immunol
Wu X, Li P, Li T, Fan Q, Wu H.
europepmc   +1 more source

Symptom burden and palliative care in patients with hematologic malignancies: a single-center experience. [PDF]

Support Care Cancer
Holopainen A, Kuittinen T, Tyynelä-Korhonen K, Lamminmäki A.   +3 more
europepmc   +1 more source

COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study. [PDF]

J Infect Dis
Hofsink Q, Lissenberg-Witte BI, Haggenburg S, Goorhuis A, Hazenberg MD, Rutten CE, den Tex P, de Vries EGE, van der Veldt AAM, Kemmeren JM, de Keizer NF, Huijgens PC, Dinmohamed AG, van Roon A, Pijpers J, van Roekel C, van den Hof S, Hahné SJM, de Gier B, Heijmans J, Nijhof IS.   +20 more
europepmc   +1 more source

Reply to comment on "Total IgE levels in patients with hematologic malignancies". [PDF]

World Allergy Organ J
Amjadi P, Hosseini F, Zaboli E, Eslami-Jouybari M, Asgarian-Omran H, Hedayatizadeh-Omran A, Omrani-Nava V, Alizadeh-Navaei R.   +7 more
europepmc   +1 more source

Racial disparities in clonal hematopoiesis and their impact on hematologic malignancies. [PDF]

J Hematol Oncol
Zhang Z, Cheng C.
europepmc   +1 more source

Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies. [PDF]

Blood Adv
Yokoyama H, Fukuhara N, Ando K, Iida H, Yamauchi T, Fukuhara S, Izutsu K, Tanoue Y, Yamamoto M, Tozaki H, Takahara E, Shoji S, Mizutani A, Morishita D, Oda R, Miyake H, Yamamoto N.   +16 more
europepmc   +1 more source